Back

Factors limiting up-titration only concern a fraction of advanced HFrEF patients and might improve over time

11 May 2024 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 11 Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Annika Weidenhammer

AKH Wien, Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
Clinical management strategies of cardiologists in heart failure with reduced ejection fraction
Doctor T. Kivrak (Elazig, TR)
Abstract Slides Video
Presentation thumbnail
Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction
Mr P. de la Fuente Lopez (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Ferric derisomaltose in hospitalised and ambulatory patients with heart failure-insights from the IRONMAN trial
Doctor M. Lee (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
An intensive nurse-led telemedicine program is effective in achieving optimized up-titration of prognostic drugs in heart failure with reduced ejection fraction patients
Mrs M. Vicente Elcano (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Effect of initiation of sacubitril/valsartan on 24 hours blood pressure in patients with heart failure with reduced ejection fraction
Mr M. Pavelko (Lutsk, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 11

The Event

Event poster

Heart Failure 2024

11 May 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Optimising guideline-directed medical therapy in the sickest patients: how far can we go?
thumbnail
Congress Presentation
Early achievement of optimal medical therapy and its impact on survival and morbidity: results from a nationwide implementation science study (BRING-UP-3 HF)
thumbnail
Congress Presentation
Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources